218 related articles for article (PubMed ID: 30540935)
1. KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer.
Xiong X; Schober M; Tassone E; Khodadadi-Jamayran A; Sastre-Perona A; Zhou H; Tsirigos A; Shen S; Chang M; Melamed J; Ossowski L; Wilson EL
Cell Rep; 2018 Dec; 25(11):3006-3020.e7. PubMed ID: 30540935
[TBL] [Abstract][Full Text] [Related]
2. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM
Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936
[TBL] [Abstract][Full Text] [Related]
3. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.
Ma B; Zhang L; Zou Y; He R; Wu Q; Han C; Zhang B
J Exp Clin Cancer Res; 2019 Jan; 38(1):23. PubMed ID: 30658712
[TBL] [Abstract][Full Text] [Related]
5. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.
Liu YN; Abou-Kheir W; Yin JJ; Fang L; Hynes P; Casey O; Hu D; Wan Y; Seng V; Sheppard-Tillman H; Martin P; Kelly K
Mol Cell Biol; 2012 Mar; 32(5):941-53. PubMed ID: 22203039
[TBL] [Abstract][Full Text] [Related]
6. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics.
Harner-Foreman N; Vadakekolathu J; Laversin SA; Mathieu MG; Reeder S; Pockley AG; Rees RC; Boocock DJ
Sci Rep; 2017 Jan; 7():40633. PubMed ID: 28094783
[TBL] [Abstract][Full Text] [Related]
7. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
[TBL] [Abstract][Full Text] [Related]
8. KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone.
Tassone E; Bradaschia-Correa V; Xiong X; Sastre-Perona A; Josephson AM; Khodadadi-Jamayran A; Melamed J; Bu L; Kahler DJ; Ossowski L; Leucht P; Schober M; Wilson EL
Oncogene; 2019 Jul; 38(29):5766-5777. PubMed ID: 31239516
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
J Cell Mol Med; 2020 Jan; 24(2):1878-1892. PubMed ID: 31881124
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
11. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
12. Cells susceptible to epithelial-mesenchymal transition are enriched in stem-like side population cells from prostate cancer.
Luo Y; Cui X; Zhao J; Han Y; Li M; Lin Y; Jiang Y; Lan L
Oncol Rep; 2014 Feb; 31(2):874-84. PubMed ID: 24316717
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway.
Ou Y; Ren H; Zhao R; Song L; Liu Z; Xu W; Liu Y; Wang S
Mol Carcinog; 2019 Aug; 58(8):1427-1437. PubMed ID: 31162747
[TBL] [Abstract][Full Text] [Related]
16. WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERT
Zhang K; Guo Y; Wang X; Zhao H; Ji Z; Cheng C; Li L; Fang Y; Xu D; Zhu HH; Gao WQ
Cancer Res; 2017 May; 77(9):2534-2547. PubMed ID: 28209613
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Klf4 in villin-positive gastric progenitor cells promotes formation and progression of tumors of the antrum in mice.
Li Q; Jia Z; Wang L; Kong X; Li Q; Guo K; Tan D; Le X; Wei D; Huang S; Mishra L; Xie K
Gastroenterology; 2012 Mar; 142(3):531-42. PubMed ID: 22155367
[TBL] [Abstract][Full Text] [Related]
18. KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas.
Tang H; Zhu H; Wang X; Hua L; Li J; Xie Q; Chen X; Zhang T; Gong Y
J Mol Cell Biol; 2017 Aug; 9(4):315-324. PubMed ID: 28651379
[TBL] [Abstract][Full Text] [Related]
19. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
20. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
Zhang N; Su P; Li X; Xi J; Li X; Xu L
Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
